Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from CLEO Diagnostics Ltd ( (AU:COV) ).
Cleo Diagnostics Ltd has announced that its 2025 Annual General Meeting (AGM) will be held on November 24, 2025. The company also informed stakeholders that the deadline for director nominations is set for October 6, 2025. This announcement is significant as it sets the stage for potential changes in the company’s leadership and strategic direction, which could impact its market positioning and stakeholder interests.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the healthcare industry, focusing on diagnostic solutions. The company is listed on the Australian Securities Exchange (ASX) under the ticker COV and is based in Melbourne, Australia.
Average Trading Volume: 82,561
Technical Sentiment Signal: Hold
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.